Clinical Trials Browser

Phase 2 × INDUSTRY × afamelanotide × Clear all

NCT05370235 2023-09-21

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V

Phase 2 Unknown

Xeroderma Pigmentosum

NCT05159752 2023-06-18

A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP)

Phase 2 Unknown

Xeroderma Pigmentosum

NCT00829192 2010-12-06

Phase II AK Study in Organ Transplant Patients

Phase 2 Unknown

Carcinoma, Squamous Cell, Keratosis, Actinic